https://www.selleckchem.com/pr....oducts/asunaprevir.h
As our understanding of microglial physiology and pathophysiology increases, we describe how we are moving toward potential therapeutic applications in MS, harnessing microglia to protect and regenerate the CNS. REM sleep behaviour disorder (RBD) is a common non-motor feature of Parkinson's disease (PD). Cannabidiol (CBD) is one of the main non-psychoactive components of Cannabis sativa and may represent an alternative route for treating RBD. This study assessed the efficacy and safety of CBD for RBD in PD. We conducted a phase II/I
Like
Comment
Share
